1. Home
  2. FNKO vs SPRO Comparison

FNKO vs SPRO Comparison

Compare FNKO & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Funko Inc.

FNKO

Funko Inc.

HOLD

Current Price

$4.39

Market Cap

162.5M

ML Signal

HOLD

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.53

Market Cap

135.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNKO
SPRO
Founded
2017
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
162.5M
135.5M
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
FNKO
SPRO
Price
$4.39
$2.53
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
487.5K
419.9K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
111.81
EPS
N/A
0.15
Revenue
$908,209,000.00
$66,802,000.00
Revenue This Year
$4.42
N/A
Revenue Next Year
$6.50
$300.00
P/E Ratio
N/A
$16.10
Revenue Growth
N/A
39.24
52 Week Low
$2.22
$0.58
52 Week High
$5.64
$3.09

Technical Indicators

Market Signals
Indicator
FNKO
SPRO
Relative Strength Index (RSI) 58.36 46.37
Support Level $4.23 $2.15
Resistance Level $4.62 $2.70
Average True Range (ATR) 0.20 0.12
MACD 0.00 -0.04
Stochastic Oscillator 41.98 23.30

Price Performance

Historical Comparison
FNKO
SPRO

About FNKO Funko Inc.

Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: